A primer on the use of machine learning to distil knowledge from data in biological psychiatry.

Journal: Molecular psychiatry
Published Date:

Abstract

Applications of machine learning in the biomedical sciences are growing rapidly. This growth has been spurred by diverse cross-institutional and interdisciplinary collaborations, public availability of large datasets, an increase in the accessibility of analytic routines, and the availability of powerful computing resources. With this increased access and exposure to machine learning comes a responsibility for education and a deeper understanding of its bases and bounds, borne equally by data scientists seeking to ply their analytic wares in medical research and by biomedical scientists seeking to harness such methods to glean knowledge from data. This article provides an accessible and critical review of machine learning for a biomedically informed audience, as well as its applications in psychiatry. The review covers definitions and expositions of commonly used machine learning methods, and historical trends of their use in psychiatry. We also provide a set of standards, namely Guidelines for REporting Machine Learning Investigations in Neuropsychiatry (GREMLIN), for designing and reporting studies that use machine learning as a primary data-analysis approach. Lastly, we propose the establishment of the Machine Learning in Psychiatry (MLPsych) Consortium, enumerate its objectives, and identify areas of opportunity for future applications of machine learning in biological psychiatry. This review serves as a cautiously optimistic primer on machine learning for those on the precipice as they prepare to dive into the field, either as methodological practitioners or well-informed consumers.

Authors

  • Thomas P Quinn
    Centre for Pattern Recognition and Data Analytics, Deakin University, Geelong, Australia.
  • Jonathan L Hess
    Department of Psychiatry and Behavioral Sciences, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
  • Victoria S Marshe
    Pharmacogenetic Research Clinic, Center for Addiction and Mental Health, Toronto, ON, Canada; Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Michelle M Barnett
    School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Anne-Christin Hauschild
    IBM Life Sciences Discovery Centre, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Computer Science, University of Toronto, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada.
  • Malgorzata Maciukiewicz
    Pharmacogenetic Research Clinic, Center for Addiction and Mental Health, Toronto, ON, Canada.
  • Samar S M Elsheikh
    Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, M5S 1A1, Canada.
  • Xiaoyu Men
    Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, M5S 1A1, Canada.
  • Emanuel Schwarz
    Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany. emanuel.schwarz@zi-mannheim.de.
  • Yannis J Trakadis
    Department of Human Genetics, McGill University, Montreal, QC, Canada.
  • Michael S Breen
    Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Eric J Barnett
    Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, New York, United States of America.
  • Yanli Zhang-James
    Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY, USA.
  • Mehmet Eren Ahsen
    Department of Business Administration, University of Illinois at Urbana Champaign, Champaign, Illinois.
  • Han Cao
    Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany. han.cao@zi-mannheim.de.
  • Junfang Chen
    Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Baden-Württemberg, J5 68159, Germany.
  • Jiahui Hou
    Department of Psychiatry and Behavioral Sciences, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
  • Asif Salekin
    Department of Electrical Engineering & Computer Science, Syracuse University, Syracuse, NY, USA.
  • Ping-I Lin
    Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, NSW, 2052, Australia.
  • Kristin K Nicodemus
    Usher Institute, University of Edinburgh, Edinburgh, EH8 9YL, UK.
  • Andreas Meyer-Lindenberg
    Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Bernstein Center for Computational Neuroscience Heidelberg-Mannheim, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Isabelle Bichindaritz
    Computer Science Department, State University of New York, Shineman Center 427, Oswego, NY 13126, USA.
  • Stephen V Faraone
    Department of Psychiatry, State University of New York Upstate Medical University, Syracuse.
  • Murray J Cairns
    School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Gaurav Pandey
    Icahn Institute for Genomics and Multiscale Biology and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: gaurav.pandey@mssm.edu.
  • Daniel J Müller
    Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, ON, Canada.
  • Stephen J Glatt
    Department of Psychiatry and Behavioral Sciences, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, 13210, USA. stephen.glatt@psychgenelab.com.